News
Novavax can finally breathe a sigh of relief – at least a small one. The Food and Drug Administration approved the company's ...
The Food and Drug Administration says it has decided to continue approving COVID-19 vaccine updates for seniors and others at ...
Key Takeaways Novavax received Food and Drug Administration approval for its new, protein-based COVID-19 vaccine.The shot, ...
The FDA has approved the Novavax COVID-19 vaccine, called Nuvaxovid, mainly for adults 65 or older, but people ages 12 to 64 with medical conditions that increase their risk of serious illness from ...
After a six-week delay, the US Food and Drug Administration has approved Novavax’s Covid-19 vaccine, according to a letter ...
Previously granted Emergency Use Authorization, Nuvaxovid is now available for individuals over 12 years of age.
The agency narrowed who can get the shot and added new study requirements that could cost the company tens of millions.
President Donald Trump's tax cut and spending bill faces a critical stress test on Wednesday as Republicans in the U.S. House ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results